Article

CIBA Vision alleges Vistakon violated lens patents

Atlanta—CIBA Vision Corp. said it is asking a federal judge in Florida to block Johnson & Johnson's Vistakon division from making, selling, and distributing silicone hydrogel contact lenses that it claims infringe upon its patents.

Atlanta-CIBA Vision Corp. said it is asking a federal judge in Florida to block Johnson & Johnson's Vistakon division from making, selling, and distributing silicone hydrogel contact lenses that it claims infringe upon its patents.

The motion seeks a temporary restraining order to block the planned U.S. launch of Vistakon's AcuVue Oasys lenses, which were introduced in Europe in April and due in U.S. eye-care professionals' offices this month.

A hearing was scheduled for Aug. 9 in the Federal District Court for the Middle District of Florida, according to CIBA Vision spokeswoman Kristie Madara.

"Ultimately, in a full trial on the merits, CIBA Vision will seek to prevent J&J/Vistakon permanently from infringing on these proprietary intellectual property rights," the company said.

Vistakon officials said their product does not infringe on the CIBA patent, and called the Nicolson patents "invalid and unenforceable." Vistakon had filed a lawsuit in February seeking a ruling on the patents.

"We are very excited about the U.S. introduction of AcuVue Oasys, and encourage eye-care professionals not to let CIBA's recent filing of this disputed motion affect adoption of AcuVue Oasys," Vistakon said in a prepared statement.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.